Cited by 11Monoclonal and Polyclonal Antibodies ResearchProtein Structure and Dynamicsvaccines and immunoinformatics approaches

FlowDesign: Improved design of antibody CDRs through flow matching and better prior distributions

Wu, Jun, Kong, Xiangzhe, Sun, Ningguan, Wei, Jing, Shan, Sisi, Feng, Fuli, Wu, Feng, Peng, Jian +3 more·2025·Cell Systems

Published version of a preprint

Abstract

Designing antibodies with desired binding specificity and affinity is essential for pharmaceutical research. While diffusion-based models have advanced the co-design of the complementarity-determining region (CDR) sequences and structures, challenges remain, including non-informative priors, incompatibility with discrete amino acid types, and impractical computational costs in large-scale sampling. To address these, we propose FlowDesign, a sequence-structure co-design approach via flow matching, offering (1) flexible prior selection, (2) direct matching of discrete distributions, and (3) enhanced efficiency for large-scale sampling. By leveraging various priors, data-driven structural models proved the most informative. FlowDesign outperformed baselines in amino acid recovery (AAR), root-mean-square deviation (RMSD), and Rosetta energy. We also applied FlowDesign to design antibodies targeting the HIV-1 receptor CD4. FlowDesign yielded antibodies with improved binding affinity and neutralizing potency compared with the antibody ibalizumab across multiple HIV mutants, validated by biolayer interferometry (BLI) and pseudovirus neutralization. This highlights FlowDesign's potential in antibody and protein design. A record of this paper's transparent peer review process is included in the supplemental information.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cels.2025.101270

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Wu, J., Kong, X., Sun, N., Wei, J., Shan, S., Feng, F., Wu, F., Peng, J., Zhang, L., Liu, Y., & Ma, J.
Affiliations
  • University of Science and Technology of China (CN)
  • Tsinghua University (CN)
Corresponding author
  • Liu, Yang
  • Ma, Jianzhu
Venue
Cell Systems
Publisher
Elsevier BV
Published
2025-06
Volume
16
Issue
6
Pages
101270
ISSN
2405-4712 (ISSN-L)
OpenAlex
W4409921893
Cited by
11
References
10
Citations by year
2026: 11
FWCI
6.35
Type
journal article
Language
en
Open access
closed
Locations
  • Cell Systems (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
Funders
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research (2022YFF1203100)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
antibody design, hypervariable region, flow matching, prior distributions, neutralizing antibodies, ibalizumab, pseudovirus neutralization, biolayer interferometry, protein design
MeSH terms
Antibodies, Humans, HIV Antibodies, HIV-1, Complementarity Determining Regions, Antibodies, Neutralizing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review